Acute Ischemic Stroke occurs when a blood clot blocks a blood vessel in the brain, leading to a sudden interruption of blood flow and oxygen. Every minute without treatment results in the loss of millions of brain cells. Without timely intervention, patients may suffer permanent disability or death.

Traditionally, the primary treatment has been intravenous thrombolysis (IVT), which is highly effective if administered within 4.5 hours of symptom onset. However, in cases of Large Vessel Occlusion (LVO), medication alone may not be sufficient.

Today, medical advancements have led to Mechanical Thrombectomy — a breakthrough treatment that significantly improves survival rates and reduces disability among stroke patients.

What is Mechanical Thrombectomy?

Mechanical Thrombectomy is a neuroendovascular procedure designed to directly remove the clot from the blocked artery in the brain. During the procedure, a small catheter is inserted through the femoral or radial artery and navigated to the clot. A specialized device is then used to extract or suction the clot.

This process restores blood flow to the affected area of the brain, halting further damage and dramatically increasing the chance of a meaningful recovery.

Indications for Mechanical Thrombectomy

• This procedure is suitable for a specific group of patients. Key criteria include:
• Presence of a Large Vessel Occlusion (LVO)
• Clinical symptoms consistent with an acute ischemic stroke
• Onset of symptoms within a treatable window – typically within 6 to 24 hours, determined by advanced imaging (CT Perfusion or MRI) that identifies salvageable brain tissue (penumbra)
• Assessment and approval by a qualified stroke specialist with radiologic support

Clinical Advantages

Research and real-world outcomes confirm that Mechanical Thrombectomy offers superior results compared to thrombolytic therapy alone, particularly for patients with LVO:

• Higher recanalization rates: Greater success in reopening blocked vessels
• Reduced disability and mortality: Increased chances of returning to independent living
• Extended treatment window: Effective even when patients arrive after the 4.5-hour window for IVT

Treatment Infrastructure and Patient Transfer

Despite its proven effectiveness, not all hospitals are equipped to perform Mechanical Thrombectomy. It requires:

• A specialized team of neurointerventional radiologists and stroke experts
• Advanced imaging equipment such as angiography suites, CT Perfusion, or MRI
• A fast and coordinated referral system

Establishing a hospital network capable of performing this procedure is critical to improving patient survival and long-term outcomes.

Readiness at Bangkok Hospital Phuket

Bangkok Hospital Phuket is proud to be one of the few hospitals in Southern Thailand equipped to perform Mechanical Thrombectomy. Our strengths include:

• A dedicated Stroke Fast Track team and neurointerventional specialists
• State-of-the-art equipment for imaging and intervention
• A comprehensive care system from emergency treatment through rehabilitation

We provide 24/7 care for stroke patients because we understand that every minute matters when it comes to brain health.

Conclusion

Mechanical Thrombectomy marks a revolutionary advancement in treating acute ischemic stroke, particularly in patients with large vessel occlusion. The combination of specialized expertise, cutting-edge technology, and a rapid response system ensures that patients have the best chance of recovery and returning to a quality life.

Disclaimer

This article is intended for public health education and should not replace professional medical advice, diagnosis, or treatment. Please consult a healthcare professional if you have any medical concerns.

References

1. Landmark Clinical Trials (2015): MR CLEAN, ESCAPE, SWIFT PRIME, EXTEND-IA, REVASCAT – these confirmed the efficacy of thrombectomy within 6 hours of symptom onset.
2. Extended Window Trials (2018): DAWN and DEFUSE 3 – demonstrated the benefits of thrombectomy up to 24 hours in select patients using imaging-based criteria.
3. Clinical Practice Guidelines:
   • American Heart Association/American Stroke Association (AHA/ASA)
   • Thai Stroke Society – updated to align with international standards